Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
出版年份 2013 全文链接
标题
Global characterization of signalling networks associated with tamoxifen resistance in breast cancer
作者
关键词
-
出版物
FEBS Journal
Volume 280, Issue 21, Pages 5237-5257
出版商
Wiley
发表日期
2013-07-22
DOI
10.1111/febs.12441
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines
- (2013) S. Radtke et al. JOURNAL OF CELL SCIENCE
- Regulation of Focal Adhesion Kinase Activation, Breast Cancer Cell Motility, and Amoeboid Invasion by the RhoA Guanine Nucleotide Exchange Factor Net1
- (2013) H. S. Carr et al. MOLECULAR AND CELLULAR BIOLOGY
- Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study
- (2013) Maria B. Lyng et al. PLoS One
- Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells
- (2012) B. Wu et al. CELL PROLIFERATION
- Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT
- (2012) D. S. Neel et al. CLINICAL CANCER RESEARCH
- MARCKS Regulates Growth and Radiation Sensitivity and Is a Novel Prognostic Factor for Glioma
- (2012) J. S. Jarboe et al. CLINICAL CANCER RESEARCH
- S100A10 is required for the organization of actin stress fibers and promotion of cell spreading
- (2012) Shurovi Sayeed et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Differential Gene Expression in Tamoxifen-Resistant Breast Cancer Cells Revealed by a New Analytical Model of RNA-Seq Data
- (2012) Kathryn J. Huber-Keener et al. PLoS One
- Expression of Abelson Interactor 1 (Abi1) Correlates with Inflammation, KRAS Mutation and Adenomatous Change during Colonic Carcinogenesis
- (2012) Konrad Steinestel et al. PLoS One
- Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells
- (2011) Ubaldo E. Martinez-Outschoorn et al. CANCER BIOLOGY & THERAPY
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance
- (2011) T. W. Miller et al. CLINICAL CANCER RESEARCH
- S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging
- (2011) Martin Nipp et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- PINA v2.0: mining interactome modules
- (2011) Mark J. Cowley et al. NUCLEIC ACIDS RESEARCH
- PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse
- (2011) P. V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
- (2011) Chen Xie et al. NUCLEIC ACIDS RESEARCH
- Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer
- (2011) C G Roberts et al. ONCOGENE
- Cytoscape 2.8: new features for data integration and network visualization
- (2010) M. E. Smoot et al. BIOINFORMATICS
- PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer
- (2010) Marleen Kok et al. BREAST CANCER RESEARCH AND TREATMENT
- Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.
- (2010) Liam Morgan et al. CANCER BIOLOGY & THERAPY
- Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
- (2010) F. Hochgrafe et al. CANCER RESEARCH
- PhosphoMARCKS drives motility of mouse melanoma cells
- (2010) Xiangyu Chen et al. CELLULAR SIGNALLING
- New Strategies in Estrogen Receptor-Positive Breast Cancer
- (2010) S. R. D. Johnston CLINICAL CANCER RESEARCH
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- The MARCKS Protein Plays a Critical Role in Phosphatidylinositol 4,5-Bisphosphate Metabolism and Directed Cell Movement in Vascular Endothelial Cells
- (2010) Hermann Kalwa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance
- (2010) I Plaza-Menacho et al. ONCOGENE
- MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
- (2009) Tao Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal Growth Factor Receptor Variant III-Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression
- (2009) J. Micallef et al. CANCER RESEARCH
- Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway
- (2009) Anchalee Techasen et al. CANCER SCIENCE
- Functional involvement of protein kinase C-βII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells
- (2009) D. S. Chappell et al. DIABETOLOGIA
- Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer
- (2009) Arzu Umar et al. MOLECULAR & CELLULAR PROTEOMICS
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome
- (2009) E K A Millar et al. ONCOGENE
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
- (2008) Yi Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast
- (2008) E K A Millar et al. BRITISH JOURNAL OF CANCER
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
- A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer
- (2008) M. Chanrion et al. CLINICAL CANCER RESEARCH
- Integrated network analysis platform for protein-protein interactions
- (2008) Jianmin Wu et al. NATURE METHODS
- Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer
- (2008) Elizabeth A. Musgrove et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now